The role of mTOR in TECs was investigated using pharmacological inhibition of mTOR kinase activity and TEC-specific deletion of Mtor. The mTOR inhibitor rapamycin induces severe thymic atrophy and reduces the number of TECs. The gene discussed is MTOR; the disease is thymus atrophy.